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Abstract
Intra-abdominal hypertension (IAH) associated with organ dysfunction defines the abdominal
compartment syndrome (ACS). Elevated intra-abdominal pressure (IAP) adversely impacts
pulmonary, cardiovascular, renal, splanchnic, musculoskeletal/integumentary, and central
nervous system physiology. The combination of IAH and disordered physiology results in a
clinical syndrome with significant morbidity and mortality. The onset of the ACS requires
prompt recognition and appropriately timed and staged intervention in order to optimize
outcome. The history, pathophysiology, clinical presentation, and management of this
disorder is outlined.
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ACS = abdominal compartment syndrome; IAH = intra-abdominal hypertension; IAP = intra-abdominal pressure; ICP = intracranial pressure; ICU =
intensive care unit; PAWP = pulmonary artery wedge pressure.
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Introduction
Intra-abdominal pressure (IAP) and its effects on respira-
tion and the abdominal contents has been the subject of
scientific study since the 19th century. Marey hypothe-
sized a reciprocal relationship between intra-thoracic pres-
sure and IAP [1]. Bert obtained pressure measurements
from anesthetized animals and concluded that diaphrag-
matic descent caused a rise in IAP, supporting Marey’s
hypothesis [1]. The potentially profound effect of IAP on
organ function was also of interest to early investigators.
Wendt inferred IAP from rectal measurements and noted a
progressive decline in urine output with increasing IAP [1].
Bradley and Bradley [2] measured renal plasma flow and
glomerular filtration rate, and monitored pressures in the
inferior vena cava and renal veins while manipulating IAP,
and concluded that the decreased renal plasma flow and
glomerular filtration rate seen with increased IAP was a
function of elevated renal venous pressure. Heinricius
noted a steady decline in inspired air with respiratory
failure and death occurring with IAP above 27–46 cmH2O
in anesthetized cats and guinea pigs [1]. Emerson, follow-
ing a series of elaborate experiments, concluded that
excessive IAP diminished venous return to the heart,
resulting in cardiovascular failure [1]. Coombs [3] demon-
strated the additive effect of hemorrhage and diminished
circulating blood volume on cardiovascular compromise
from elevated IAP.
Baggot [4], in 1951, described the clinical effects of
abdominal wound closure under tension after a dehis-
cence or ‘abdominal blow-out’. He cited the example of
infant death after particularly forcible reductions of abdom-
inal viscera during repair of congenital abdominal wall
defects. He also noted the similarly high mortality associ-Critical Care    Vol 4 No 1 Bailey and Shapiro
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ated with analogous procedures in adults with high-
tension repairs of acquired abdominal wall defects. Refer-
encing earlier investigations, he concluded that death was
a result of respiratory dysfunction. Baggot coined the
phrase ‘acute tension pneumoperitoneum’, believing that
trapping a large volume of air within the abdomen during
wound closure caused the elevation in IAP. He recom-
mended that tight abdominal closures and dressings be
abandoned in favor of loose dressings placed on the open
abdomen, primarily to prevent entry of microbes. Interest-
ingly Ogilvie [5], more than a decade earlier, described a
‘dodge that has twice helped me out’ in order to avoid
closing a ‘burst abdomen’ under tension. He describes the
use of Vaseline impregnated canvas or cotton cloth
sutured to the wound edges in order to cover abdominal
contents. After this he enhanced epithelialization with
‘pinch grafts … liberally sprinkled’ on the granulating
wound surface. He recommended a waiting period of
several months to allow for wound contracture before any
attempt at repair of the resultant ventral hernia.
Despite these early contributions, the clinical and patho-
physiologic significance of elevated IAP went largely
unrecognized. Given the significant mortality associated
with repair of congenital abdominal wall defects, pediatric
surgeons developed the prosthetic silo technique for
gradual reduction of abdominal viscera. This methodology
resulted in a marked reduction in mortality in these
patients and revisited the topic of the adverse conse-
quences of compressed abdominal viscera and elevation
in IAP [6]. Also, the advent of laparoscopy renewed inter-
est in the physiologic consequences of elevated IAP asso-
ciated with pneumoperitoneum. Several investigators
demonstrated altered hemodynamics associated with ele-
vation in IAPs above 20 cmH2O. Although these investiga-
tions demonstrated alteration in various cardiovascular
indices, no adverse clinical effects occurred. In keeping
with the findings of Coombs [3], the authors of one such
study [7] recommended caution with the use of
laparoscopy in patients with impaired cardiovascular func-
tion, anemia, or hypovolemia.
The 1980s ushered in a renewed interest in the patho-
physiologic effects of elevated IAP. Several authors pub-
lished reports of impaired organ function (particularly
renal) associated with presumed elevated IAP, with clini-
cal improvement after abdominal decompression. Kron et
al [8], in 1984, reported the first series in which IAP was
measured and used as a criterion for abdominal decom-
pression, followed by improvement in organ function. Kron
et al were the first to use the phrase ‘abdominal compart-
ment syndrome’ (ACS).
Pathophysiology
The ‘normal’ barometric environment of the abdominal
compartment and its regulation has long been a subject of
interest. Hammermilk is credited with providing the first
definitive statement on normal IAP. In 1858 he concluded
that the normal intra-abdominal environment was a
vacuum and believed that the visceral surfaces of its con-
tents were opposed by a ‘horror vacui’. Measurement of
IAP was described by Braune in 1865; he attempted to
measure positive IAP by the use of rectal bougies. He
found the pressures within the abdomen varied with posi-
tion (lowest horizontal and highest vertical) and contrac-
tion of abdominal musculature. His studies were criticized
because the measurements were based on barometric
conditions within hollow viscera. Odebrecht in 1875
tested pressures within the urinary bladder and confirmed
the findings of Braune [1]. Multiple investigators have
since confirmed the normal pressure environment of the
abdomen to be atmospheric or subatmospheric, and to
vary inversely with intra-thoracic pressure during normal
spontaneous ventilation [1,3,9].
Measurement of intra-abdominal pressure
Contemporary measurement of IAP outside of the labora-
tory is accomplished by a variety of means. These include
direct measurement of IAP by means of an intra-peritoneal
catheter, as is done during laparoscopy. Bedside mea-
surement of IAP has been accomplished by transduction
of pressures from indwelling femoral vein, rectal, gastric,
and urinary bladder catheters. Of these methods, mea-
surement of urinary bladder and gastric pressures are the
most common clinical applications [8–12]. In 1984 Kron
et al [8] reported a method by which to measure IAP at
the bedside with the use of an indwelling Foley catheter
Sterile saline (50–100 cm3) is injected into the empty
bladder through the indwelling Foley catheter. The sterile
tubing of the urinary drainage bag is cross-clamped just
distal to the culture aspiration port. The end of the
drainage bag tubing is connected to the Foley catheter.
The clamp is released just enough to allow the tubing
proximal to the clamp to flow fluid from the bladder, then
reapplied. A 16-gauge needle is then used to Y-connect a
manometer or pressure transducer through the culture
aspiration port of the tubing of the drainage bag. Finally,
the top of the symphysis pubic bone is used as the zero
point with the patient supine (Fig. 1).
An alternative bedside technique has been described in
which intragastric pressure measurements are taken from
an indwelling nasogastric tube. This method has been vali-
dated and found to vary within 2.5 cmH2O of urinary
bladder pressures [12]. Of these techniques, measure-
ment of urinary bladder pressure appears to have gained
widest clinical acceptance and application [9,13,14].
The terms intra-abdominal hypertension (IAH) and ACS
have sometimes been used interchangeably. It is impor-
tant to recognize the distinction between these entities.
IAH exists when IAP exceeds a measured numeric para-25
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meter. This parameter has generally been set at between
20 and 25 mmHg [10,13]. ACS exists when IAH is
accompanied by manifestations of organ dysfunction, with
reversal of these pathophysiologic changes upon abdomi-
nal decompression [9,10,13–15].
The adverse physiologic effects of IAH impact multiple
organ systems. These include pulmonary, cardiovascular,
renal, splanchnic, musculoskeletal/integumentary (abdomi-
nal wall), and central nervous system [9,13–15].
Pulmonary dysfunction
Elevated IAP has a direct effect on pulmonary function. Pul-
monary compliance suffers with resultant progressive
reduction in total lung capacity, functional residual capacity
and residual volume [9]. This is manifested clinically by ele-
vated hemidiaphragms on chest radiography. These
changes have been demonstrated with IAP above
15 mmHg [16]. Respiratory failure secondary to hypoventi-
lation results from progressive elevation in IAP. Pulmonary
vascular resistance increases as a result of reduced alveo-
lar oxygen tension and increased intrathoracic pressures.
Ultimately, pulmonary organ dysfunction is manifest by
hypoxia, hypercapnia and increasing ventilatory pressure.
Decompression of the abdominal cavity results in nearly
immediate reversal of respiratory failure [9].
Cardiovascular dysfunction
Elevated IAP is consistently correlated with reduction in
cardiac output. This has been demonstrated with IAP
above 20 mmHg [17]. Reduction in cardiac output is a
result of decreased cardiac venous return from direct
compression of the inferior vena cava and portal vein.
Increased intrathoracic pressure also results in reduced
inferior and superior vena cava flow. Maximal resistance to
vena cava blood flow occurs at the diaphragmatic caval
hiatus. This is related to the abrupt pressure gradient
between the abdominal and chest cavities. Elevated
intrathoracic pressure causes cardiac compression and
reduction in end-diastolic volume. Elevations in systemic
vascular resistance result from the combined effect of
arteriolar vasoconstriction and elevated IAP. These
derangements result in reduced stroke volume that is only
partly compensated for by increases in heart rate and con-
tractility. The Starling curve is thus shifted down and to the
right, and cardiac output progressively falls with increasing
IAP [9,16,17]. These derangements are exacerbated by
concomitant hypovolemia [3].
Increased intrapleural pressures resulting from transmitted
intra-abdominal forces produce elevations in measured
hemodynamic parameters. including central venous pres-
sure and pulmonary artery wedge pressure (PAWP). Sig-
nificant hemodynamic changes have been demonstrated
with IAP above 20 mmHg [9,16]. Animal models have
shown that approximately 20% of IAP is transmitted to the
chest cavity from upward bulging of the hemidiaphragms
[17]. Accurate prediction of end-diastolic filling pressures
by means of equations that subtract a component of
pleural pressure from PAWP have not been demonstrated
to be consistently reliable, however [16,18]. Recent tech-
nologic advances have allowed measurement of right ven-
tricular end-diastolic volumes by means of a rapid
thermistor flow-directed pulmonary artery catheter. This
technology has been shown to be a more accurate predic-
tor of left ventricular end-diastolic volume and cardiac
index than PAWP measurements [18,19]. The cardiovas-
cular environment produced by elevated IAP may be more
reliably discerned by reliance on this methodology for
hemodynamic measurements.
Renal dysfunction
Graded elevations in IAP are associated with incremental
reductions in measured renal plasma flow and glomerular
filtration rate. This results in a decline in urine output,
beginning with oliguria at IAP of 15–20 mmHg and pro-
gressing to anuria at IAP above 30 mmHg [2,9,20]. The
mechanism by which renal function is compromised by
elevated IAP is multifactorial. Early investigations [2]
pointed to elevated renal venous pressure as a means that
is sufficient to account for renal insufficiency associated
with IAH. Later investigators criticized these studies for
failure to establish the effect of direct ureteral compres-
sion on renal dysfunction. Subsequent investigations
showed no significant difference in renal dysfunction when
ureteral stents were used in a subgroup of patients [20].
The adverse renal physiology associated with IAH is pre-
renal and renal. Prerenal derangements result from altered
cardiovascular function and reduction in cardiac output
Figure 1
Measuring the abdominal compartment pressure having injected fluid
into the bladder, clamping distal to the aspiration port, and hooking up
the pressure transducer apparatus to the aspiration port.with decreased renal perfusion. Reduced cardiac output is
not solely responsible for renal insufficiency associated
with elevated IAP because correction of cardiac indices
does not completely reverse impairment in renal function.
Renal parenchymal compression produces alterations in
renal blood flow secondary to elevated renal vascular
resistance. This occurs by compression of renal arterioles
and veins. Resistance changes have been measured with
graded elevation in IAP. Renal vascular resistance ranges
from 500% or greater at 20 mmHg to 1500% or greater
at 40 mmHg, and is many times greater than simultane-
ously measured systemic vascular resistance [20].
The combined effect of prerenal and renal derangements
produces progressive reduction in renal plasma flow and
glomerular filtration. This results in elevated levels of circu-
lating renin, antidiuretic hormone, and aldosterone, which
further elevate renal and systemic vascular resistance. The
result is azotemia with renal insufficiency and renal failure
that is only partly correctable by improvement in cardiac
output [2,9,20].
Portosystemic visceral dysfunction
Splanchnic blood flow abnormalities that result from IAH
are not limited to the kidneys. Impaired liver and gut perfu-
sion have also been demonstrated with elevation in IAP.
Severe progressive reduction in mesenteric blood flow
has been shown with graded elevation in IAP from approx-
imately 70% of baseline at 20 mmHg, to 30% at
40 mmHg. Intestinal mucosal perfusion as measured by
laser flow probe has been shown to be impaired at IAP
above 10 mmHg, with progressive reductions in flow cor-
responding to increased measured abnormalities in
mesenteric perfusion. Metabolic changes that result from
impaired intestinal mucosal perfusion have been shown by
tonometry measurements that demonstrate worsening aci-
dosis in mucosal cells with increasing IAH [21]. Similarly,
measured abnormalities in intestinal oxygenation have
been shown with elevations of IAP above 15 mmHg.
Impairment in bowel tissue oxygenation occurs without
corresponding reductions in subcutaneous tissue oxy-
genation, indicating the selective effect of IAP on organ
perfusion [22]. Not surprisingly, reductions in mesenteric
flow have been shown to be greatly exacerbated in the
setting of resuscitation after hemorrhagic shock [23]. 
Impaired bowel perfusion has been linked to abnormalities
in normal physiologic gut mucosal barrier function, result-
ing in a permissive effect on bacterial translocation. This
may contribute to later septic complications associated
with organ dysfunction and failure [24]. 
Adverse effects of IAP on hepatic arterial, portal, and
microcirculatory blood flow have also been shown with
pressures above 20 mmHg. A progressive decline in per-
fusion through these vessels occurs as IAP increases,
despite cardiac output and systemic blood pressure being
maintained at normal levels. Splanchnic vascular resis-
tance is a major determinant in the regulation of hepatic
arterial and portal venous blood flow. Elevated IAP can
become the main factor in establishing mesenteric vascu-
lar resistance and ultimately abdominal organ perfusion
[25]. These abnormalities are amplified in the setting of
hypovolemia and hemorrhage, and are only partly cor-
rectable by physiologic and resuscitative improvements in
cardiac output [21–25].
Although technically not a component of the abdominal
cavity itself, the abdominal wall is also adversely impacted
by elevations in IAP. Significant abnormalities in rectus
muscle blood flow have been documented with progres-
sive elevations in IAP. These perfusion abnormalities are
roughly on par with changes in abdominal visceral perfu-
sion with graded increases in IAP. Clinically, this derange-
ment is manifest by complications in abdominal wound
healing, including fascial dehiscence, and surgical site
infection [26].
Central nervous system dysfunction
Elevations in intracranial pressure (ICP) have been shown
in both animal and human models with elevated IAP.
These pressure derangements have been shown to be
independent of cardiopulmonary function and appear to
be primarily related to elevations in central venous and
pleural pressures. The exact mechanism of elevated ICP
associated with IAH remains to be definitively elucidated,
but appears to be a function of impaired cranial venous
outflow. Elevated IAP has been demonstrated to coexist
with obesity and increased abdominal girth. This is pro-
posed as a chronic form of IAH and has been hypothe-
sized as a mechanism for benign ICP, which is also
referred to as pseudotumor cerebri. Abdominal decom-
pression and weight loss via bariatric surgery have been
shown to reverse benign ICP associated with IAH [9,27].
Clinical presentation
ACS exists when elevated IAP or IAH is associated with
organ dysfunction. Mechanistically this occurs when there
is a pressure–volume disparity between the abdominal
cavity and its contents. The result is elevated IAP, causing
the adverse physiologic consequences described above.
Incidence and risk factors
The exact incidence of ACS is yet to be established, but it
is clearly increased in certain population groups. These
include patients with severe blunt and penetrating abdom-
inal trauma, ruptured abdominal aortic aneurysms,
retroperitoneal hemorrhage, pneumoperitoneum, neo-
plasm, pancreatitis, massive ascites, and liver transplanta-
tion [14]. Massive fluid resuscitation, accumulation of
blood and clot, bowel edema, and forced closure of a non-
compliant abdominal wall are common factors among
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nal burn eschars cause extrinsic compression of the
abdominal wall, leading to increases in IAP [9]. Among the
trauma population, the group that is especially at risk
includes those patients undergoing abbreviated or
‘damage control’ laparotomy, especially with intra-abdomi-
nal packing [9,28]. In one prospective series of 145
patients who were identified as being at risk for develop-
ment of the ACS [10] the incidence was reported as
14%. The incidence following primary closure after repair
of ruptured abdominal aortic aneurysm is reported in one
series as 4% [9].
Risk factors for ACS are summarized in Table 1.
Diagnosis
The ACS exists when IAH is associated with organ dys-
function that is reversible upon abdominal decompression.
The patients at risk have been previously described.
Organ dysfunction occurs in multiple systems, as previ-
ously mentioned.
Clinical manifestations of organ dysfunction include respi-
ratory failure that is characterized by impaired pulmonary
compliance, resulting in elevated airway pressures with
progressive hypoxia and hypercapnia. Extremely high
driving pressures may be required to maintain minimally
sufficient tidal volumes, often with loss of delivered tidal
volume by distension of ventilatory tubing. Some authors
report pulmonary dysfunction as the earliest manifestation
of ACS [14]. Chest radiography may show elevated
hemidiaphragms with loss of lung volume [29].
Hemodynamic indicators include elevated heart rate,
hypotension, normal or elevated PAWP and central venous
pressure, reduced cardiac output and elevated systemic and
pulmonary vascular resistance [9,29]. Measurement of right
ventricular end-diastolic volume may be a more accurate pre-
dictor of a patient’s position on the Starling curve [18,19].
Impairment in renal function is manifest by oliguria pro-
gressing to anuria with resultant azotemia. Renal insuffi-
ciency as a result of IAH is only partly reversible by fluid
resuscitation. Renal failure in the absence of pulmonary
dysfunction is not likely to be the result of IAH [14,29].
Elevated ICP is an additional clinical manifestation of ACS
[29]. Clinical confirmation of IAH requires bedside mea-
surements indicative of IAP. These techniques include
transduction of gastric, rectal, and bladder pressures
[8,11,12]. A technique for measurement of bladder pres-
sure has been described by Kron et al [8] (discussed
above). Experimental and clinical data indicate that IAH is
present above an IAP of 20 mmHg [10,13].
Management
Definitive management of ACS is based on optimal timing
and staging of abdominal decompression and is predi-
cated on early identification of at-risk patients. 
Surveillance for IAH and ACS requires close monitoring of
relevant physiologic parameters, including indicators of
IAP. The decision to intervene surgically is based on the
clinical decision that improvement in organ dysfunction
can best be accomplished by abdominal decompression,
which is the treatment required [9,14].
Prevention
The earliest and potentially most effective means of
addressing this disorder is by recognition of patients who
are at risk and pre-emptive interventions designed to mini-
mize the chances for development of IAH. These deci-
sions are primarily made during laparotomy and involve
choices regarding the decision to terminate an operation
because of overwhelming nonoperative disorders in
patient physiology (hypothermia, acidosis, coagulopathy)
and the method of abdominal wound closure [30]. Various
types of mesh closures of the abdominal wall and other
alternative means of abdominal content coverage have
been described [5,9,13,14,31,32]. There is evidence [31]
that ACS may be preventable by use of absorbable mesh
in high-risk injured patients undergoing laparotomy.
Achieving optimal resuscitation rather than over-resuscita-
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Table 1
Risk factors for abdominal compartment syndrome
Severe penetrating and blunt abdominal trauma
Ruptured abdominal aortic aneurysm
Retroperitoneal hemorrhage
Pneumoperitoneum
Neoplasm
Pancreatitis
Massive ascites
Liver transplantation
Abdominal wall burn eschar
Table 2
Abdominal compartment grading system
Bladder pressure
Grade (mmHg) Recommendation
I 10–15 Maintain normovolemia
II 16–25 Hypervolemic resuscitation
III 26–35 Decompression
IV >35 Decompression and re-explorationtion is a potentially preventable complication in intensive
care management. Multiple indicators of effective resusci-
tation have been evaluated. Lactate, base deficit, and
gastric mucosal pH appear to be reliable indicators to
guide resuscitative interventions [33].
Surgical intensive care unit management
Identifying patients in the intensive care unit (ICU) at risk
for developing ACS with constant surveillance can help
lead to prevention. A further strategy is based on recogni-
tion of IAH and resultant organ dysfunction. A four-stage
grading scheme base on IAP has been developed, tested,
and proposed as a useful ACS management tool (Table 2)
[10]. These stages are based on measured bladder pres-
sures. This methodology correlates worsening organ dys-
function with increasing bladder pressures, with 100% of
patients showing pulmonary, cardiovascular, and renal
dysfunction with pressures greater than 35 mmHg.
Meldrum  et al [10] perform simple bedside decompres-
sion for bladder pressures from 26 to 35 mmHg, but rec-
ommend formal abdominal exploration with pressures
greater than 35 mmHg in anticipation of significant intra-
abdominal ischemia. This is based on impaired bowel cap-
illary perfusion at IAP greater than 35 mmHg.
Alternative means for surgical decision making are based
on clinical indicators of adverse physiology, rather than on
a single measured parameter. In the setting of IAH,
abdominal decompression has been recommended with
any coexisting deterioration in pulmonary, cardiovascular,
or renal function. Additionally, with IAH that is unrespon-
sive to standard intervention and with indicators of bowel
ischemia (acidosis by tonometry or dusky bowel seen
through transparent coverage material), decompression is
recommended [9,34]. Worsening hypercapnia and pul-
monary compliance have been identified as critical indica-
tors of pulmonary failure that warrant emergent abdominal
decompression in the setting of IAH [13].
Abdominal decompression and wound management
Once the decision is made to proceed to surgical decom-
pression and the need for intervention is established, the
location and possibly transportation requirements for per-
forming this procedure must be decided. A decision to
perform the decompression in the ICU is a function of the
ventilatory requirements of the patient and the risk associ-
ated with transport to the operating room. Although
optimal respiratory support may be available in the ICU,
this location is generally suboptimal for controlling surgical
bleeding. The potential for major intra-abdominal hemor-
rhage varies, but it can be significant in patients with ACS.
Operative planning must include contingencies for man-
agement of surgical bleeding encountered when decom-
pression is performed in the ICU, which may require
repacking and immediate transport to the operating room.
It is mandatory that an operating room be immediately
available and appropriately staffed before beginning an
ICU abdominal decompression. Patients who require high
airway pressures for adequate gas exchange require
transport on a high-flow pressure ventilator powered by a
battery source [14].
Abdominal decompression may itself precipitate adverse
physiologic and metabolic events that should be antici-
pated. These include a large increase in pulmonary com-
pliance with resultant elevation in minute ventilation and
respiratory alkalosis unless appropriate ventilatory
changes are instituted. ‘Washout’ of accumulated intra-
abdominal products of anaerobic metabolism may result in
a bolus of acid and potassium systemically delivered to
the heart. This may result in an adverse cardiac event such
as an arrhythmia or asystole. Anticipating, recognizing, and
treating these effects is of critical importance [9,14].
Under most circumstances following abdominal decom-
pression, immediate primary fascial closure is obviated.
Alternative means for coverage of the abdominal contents
include skin closure with towel clips or suture, abdominal
wall advancement flaps, plastic or silicone coverage, and
mesh interposition grafts (Fig. 2). Patients undergoing
decompressive laparotomy are by definition at risk for
future redevelopment of ACS, and strong consideration
should be given to providing for re-exploration and a
staged closure. This may include fascial closure after a
period of 7–10 days versus placement of split thickness
skin grafts on a granulating surface followed by delayed
repair of the resulting abdominal wall hernia after several
months [9,13,14,30–32]. Finally, early management of the
open abdomen must include recognition for significant
fluid losses and fluid replacement [14].
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Figure 2
The abdomen was reopened due to abdominal compartment syndrome
and approximated with an intravenous bag, sterile side down.Outcomes
The ACS is a condition with a potentially high lethality that
must be recognized early and effectively managed in order
to optimize outcome. Most deaths associated with ACS
are due to sepsis or multiple organ failure. Mortality asso-
ciated with this condition has been reported in 10.6–68%
of patients [9,10,14,28]. In one series [14], nonsurvivors
tended toward a more fulminant course, with the majority
of deaths occurring within the first 24 h of injury. There is
some evidence that the syndrome may be prevented in
high-risk patient groups by selective mesh closure of the
abdominal wall after laparotomy [28,31]. 
Further study is needed to better establish the incidence,
long-term and short-term morbidity, and mortality of this
condition.
Conclusion
The abdominal compartment syndrome is defined as intra-
abdominal hypertension associated with organ dysfunc-
tion. Adverse physiology has been demonstrated in
pulmonary, cardiovascular, renal, musculoskeletal/integu-
mentary, and central nervous system function. Identifica-
tion of patients at risk, early recognition, and appropriately
staged and timed intervention is key to effective manage-
ment of this condition.
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